Prostate cancer is the most frequently diagnosed cancer and the second leading cause of cancer-related death among men in the United States[1]Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression. Statistically, one in eight men

CHEMOTHERAPY TREATMENT When you average the benefit of chemotherapy across all cancers, the overall gain is just 2%. That may sound like a low cure rate—but that’s not what it is. It’s not 2% cured. It’s 2% who don’t die within five years. That’s a far cry from healing. Chemotherapy